Navigation Links
New Kit Takes the Uncertainty Out of Lymphoma Diagnosis

ALBUQUERQUE, New Mexico, November 9, 2011 /PRNewswire/ --

A new diagnostic kit which takes the uncertainty out of lymphoma diagnosis, has been launched at the Veterinary Cancer Society's annual conference this month.

Developed by PetScreen ( in the UK, the announcement is a significant breakthrough in the diagnosis of canine lymphoma with the major benefit being that it is able to differentiate between patients with lymphadenopathy due to lymphoma and lymphadenopathy due to other ailments such as lymphoid hyperplasia.  

The announcement also signals a partnership and commercial venture between PetScreen Ltd and Tridelta Development Ltd to jointly develop manufacture and market a unique range of veterinary cancer diagnostic kits under the banner of 'Tri-Screen' ( PetScreen has established the first reference laboratory offering the Advanced Lymphoma Blood Test (ALBT) utilising the Tri-Screen Canine Lymphoma assay kit.  The kit is available now to enable laboratories worldwide to offer veterinarians this advanced testing system.

For the past two years, PetScreen's research team have been busy characterising and identifying the biomarkers used in their earlier lymphoma blood test.  They found that two of the markers are Acute Phase Proteins (APP's).  Although APP's have been investigated in veterinary medicine for some time PetScreen has developed a unique multi-marker approach which led to the development of patented and copyrighted analytical algorithms which combine the relative values of both Haptoglobin and C-Reactive Protein (CRP) in serum.  

By enlisting the support of vets in the UK and USA the assay has been rigorously tested with 194 canine patients with lymphoma, benign lymphoid hyperplasia and other diseases with similar presentation to lymphoma as well as healthy dogs.

By testing the acute phase proteins using immunoassay, PetScreen achieved excellent levels of high performance, reproducibility and objectivity. The combination of the three diagnostic elements enables differentiation with a very high degree of sensitivity and specificity … ensuring an appropriate treatment regimen can begin at a critical early stage of disease identification and development.

In order to make this available to a global reference laboratory market, a partner with a unique understanding of APP diagnostic kit manufacture and marketing was required … it quickly became apparent that Tridelta's reputation and experience with the international pharmaceutical industry in this niche sector qualified their preferred partner status.  Each company brings its own strengths to the Tri-Screen brand of diagnostic kits.  For Tridelta it is an important step into the companion animal marketplace; for PetScreen, the opportunity to globalise and advance their veterinary diagnostics expertise in this important and rapidly emerging sector.

For further information please contact:

SOURCE PetScreen
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Graphenes quantum leap takes electronics a step closer
2. Cord Blood America Announces Reverse Stock Split Takes Effect Monday, May 9, 2011
3. CPTA Takes a Step Toward Improving Patient Access to Physical Therapy Services
4. Computer memory takes a spin
5. Terso Solutions RFID Jump Start Takes the Risk Out of Implementing RFID for Hospitals and Research Laboratories Looking to Streamline Operations and Improve Regulatory Compliance
6. Founder and ex-CEO of eSolar Asif Ansari takes the helm of Canadian startup Morgan Solar
7. Prototype Software from Elektas Research Group Takes First Place in Two Autosegmentation Contests at MICCAI 2010
8. Case Western Reserve University-led team takes high resolution photo of a K+ channel
9. New test takes guesswork out of diagnosing early stage Alzheimers disease
10. BioSpec Global Solutions Inc, takes delivery of new TOGs 3000 Home edition for the U.S. and international markets
11. Medizone International Takes Aim at the Bioterrorism Countermeasures Arena
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... ... year and one of the premier annual events for pharmaceutical manufacturing: 2015 Annual ... November 2015, where ISPE hosted the largest number of attendees in more than ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... to a new market research report "Oligonucleotide Synthesis Market ... Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User ... to 2020", published by MarketsandMarkets, the market is expected ... 1,078.1 Million in 2015, at a CAGR of 10.1% ...
(Date:11/24/2015)... Massachusetts , November 24, 2015 SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ... , Chief Financial Officer, will participate in the Piper Jaffray 27 ... , NY on Tuesday, December 1, 2015, at 8:30 a.m. ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that the remaining 11,000 post-share consolidation (or 1,100,000 ... (the "Series B Warrants") subject to the previously ... November 23, 2015, which will result in the ... effect to the issuance of such shares, there ...
Breaking Biology Technology:
(Date:11/17/2015)... , November 17, 2015 ... 19 novembre  2015.  --> Paris , ... --> DERMALOG, le leader de l,innovation biométrique, a ... fois passeports et empreintes sur la même surface de ... passeports et l,autre pour les empreintes digitales. Désormais, un ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
Breaking Biology News(10 mins):